Publications by the researcher in collaboration with Elisa Escudero Pastor (63)

2018

  1. Pharmacokinetics of deflazacort in rabbits after intravenous and oral administration and its interaction with erythromycin

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 41, Núm. 1, pp. e10-e15

2013

  1. Pharmacokinetics of marbofloxacin in rabbit after intravenous, intramuscular, and subcutaneous administration

    Research in Veterinary Science, Vol. 94, Núm. 3, pp. 698-700

2012

  1. Short Communication: Fluoroquinolone susceptibility of Staphylococcus aureus strains isolated from commercial rabbit farms in Spain

    Veterinary Record, Vol. 170, Núm. 20

2011

  1. Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats

    Veterinary Journal, Vol. 188, Núm. 1, pp. 92-95

2010

  1. Pharmacokinetics and milk penetration of difloxacin after a long-acting formulation for subcutaneous administration to lactating goats

    Journal of Dairy Science, Vol. 93, Núm. 7, pp. 3056-3064

  2. Short communication: Fluoroquinolone susceptibility of Staphylococcus aureus strains isolated from caprine clinical mastitis in southeast Spain

    Journal of Dairy Science, Vol. 93, Núm. 11, pp. 5243-5245

2009

  1. Atlas de plantas medicinales y tóxicas

    Departamento de Farmacología, Toxicología y Medicina Legal y Forense, Universidad de Córdoba

  2. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep

    Veterinary Journal, Vol. 180, Núm. 3, pp. 343-347

  3. Pharmacokinetics and milk penetration of difloxacin after subcutaneous administration as a long-acting poloxamer 407 gel formulation to lactating goats

    XXXI Congreso de la Sociedad Española de Farmacología

  4. Pharmacokinetics of difloxacin after intravenous and subcutaneous administration, and as a long-acting poloxamer 407 gel formulation with carboxy-methylcellulose for subcutaneous administration to goats

    XXXI Congreso de la Sociedad Española de Farmacología

2008

  1. Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 31, Núm. 1, pp. 77-82

  2. Pharmacokinetics of danofloxacin after single dose intravenous, intramuscular and subcutaneous administration to loggerhead turtles Caretta caretta

    Diseases of Aquatic Organisms, Vol. 82, Núm. 3, pp. 231-236

2007

  1. Development of a method for the determination of ibafloxacin in plasma by HPLC with flourescence detection and its application to a pharmacokinetic study

    Journal of Chromatographic Science, Vol. 45, Núm. 5, pp. 242-245

  2. Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 30, Núm. 1, pp. 18-24

  3. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of difloxacin in sheep

    Research in Veterinary Science, Vol. 83, Núm. 2, pp. 234-238

  4. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 30, Núm. 1, pp. 74-79

  5. Pharmacokinetics and milk penetration of ibafloxacin after intravenous administration to lactating goats

    Canadian Journal of Veterinary Research, Vol. 71, Núm. 1, pp. 74-76

  6. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats

    Veterinary Journal, Vol. 173, Núm. 2, pp. 452-455

  7. Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats

    Journal of Dairy Science, Vol. 90, Núm. 9, pp. 4219-4225

  8. Pharmacokinetics of danofloxacin 18% in lactating sheep and goats

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 30, Núm. 6, pp. 572-577